Facebook to Buy Messaging App WhatsApp; Garmin Ltd. Hits New 1-year High on Earnings

Follow this company

Companies Mentioned

02/20/2014 [ACCESSWIRE]

Facebook, Inc. (NASDAQ: FB) – For an in-depth report on Facebook, Inc. follow: www.BullTrends.com/stockquote/FB

Shares of the world’s biggest social networking company, Facebook, closed up a modest 1.13% on Wednesday, but hit a new high of $69.08 during intra-day trading. Facebook announced that it will be buying mobile messaging service WhatsApp for $19 billion in cash and stock. This is the company’s largest acquisition to date and bigger than any acquisition that Google, Microsoft, or Apple has ever done. The stock traded a little more than 64 million shares.

Garmin Ltd. (NASDAQ: GRMN) – For an in-depth report on Garmin Ltd. follow: www.BullTrends.com/stockquote/GRMN

Shares of Garmin Ltd. closed up 9.56% on Wednesday and hit a new one-year high of $52.72 during intra-day trading. The stock was one of the biggest gainers on the NASDAQ. The company reported Q4 adjusted earnings per share of 76 cents and revenue of $759.7M, compared to expectations of 62 cents and $712.78M, respectively. The midpoint of the company's FY14 profit view was in-line with estimates. Garmin's FY14 revenue forecast of $2.6B-$2.7B also surpassed the consensus forecast of $2.58B. The company said, "We anticipate gross margins will improve to 54%-55% in FY14 as segment mix continues to shift toward higher margin segments.

Ariad Pharmaceuticals Inc. (NASDAQ: ARIA) – For an in-depth report on Ariad Pharmaceuticals Inc. follow: www.BullTrends.com/stockquote/ARIA

Ariad Pharmaceuticals closed down 2.16% on Wednesday on a little over 13 million shares traded. The company announced that it will present at the RBC Capital Markets Healthcare Conference being held in New York City. Harvey J. Berger, M.D., chairman and chief executive officer, will provide an overview of the Company’s business on Wednesday, February 26, at 3:05 p.m. (ET). ARIAD Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts and Lausanne, Switzerland, is an integrated global oncology company focused on transforming the lives of cancer patients with breakthrough medicines.

Fresh Healthy Vending International, Inc. (OTCBB: VEND) – For an in-depth report on Fresh Healthy Vending International, Inc. follow: www.BullTrends.com/stockquote/VEND

Shares of VEND closed up 4.90% on Wednesday and hit a new 52-week high of $6.00 during intra-day trading. The stock was one of the most active stocks trading in the OTCBB market. The company announced earlier in the week the appointment of Mark Cole as the company’s chief financial officer, effective February 18, 2014. “Coming from a storied company like Crocs, which grew from $100 million to over $854 million in just two years, we knew Mark would be an exceptional addition to the Fresh Healthy Vending team,” said Alex Kennedy, CEO of Fresh Healthy Vending.


Wondering what your next move should be in the market? BullTrends.com can help lead the way. For free access to our complete stock reports, take a few minutes to register with us by clicking this link: http://www.bulltrends.com/ 


Disclosure: BullTrends.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please read our report and visit our website, for complete risks and disclosures.


Leave a comment...

Your Name